01 Con fj dential – not for distribution
02 TruSpine Technologies Limited The information in this presentation is in summary form and should not be relied upon as The forward-looking statements included in this presentation involve subjective judgment a complete and accurate representation of TruSpine Technologies Limited and its various and analysis and may cause actual results to differ materially from those expressed business activities. While management has taken every effort to ensure the accuracy of or implied in such statements and are subject to significant business, economic and the material in the presentation, the presentation is provided for information purposes competitive uncertainties, risks and contingencies, many of which are outside the control only. No representation or warranty, express or implied, is or will be made by TruSpine of, and are unknown to TruSpine Technologies Limited . These risks include, among others, Technologies Limited or its officers, directors, employees or advisers as to the fairness, changes in the economic climate. If one or more of these risks materialises, or if underlying accuracy, completeness or correctness of the information, opinions and conclusions assumptions prove incorrect, TruSpine Technologies Limited ’s actual results may vary contained in, or implied by, this presentation, or as to the reasonableness of any assumption, materially from those expected, estimated or projected. Given these uncertainties, forecasts, prospects or returns contained in, or implied by, this presentation or any part of you are cautioned not to place undue reliance on forward-looking statements. These it. The presentation may include information derived from third party sources that has not forward-looking statements are based on information available to us as of the date of this been independently verified. presentation. Except as required by law or regulation (including any future stock exchange listing rules) we undertake no obligation to update these forward-looking statements. This presentation should be read in conjunction with other technical information and reports prepared by independent consultants for TruSpine Technologies Limited. This presentation is subject to change without notice. Subject to any obligations under applicable laws, regulations or securities exchange listing rules. TruSpine Technologies This presentation contains certain forward-looking statements with respect to the Limited disclaims any obligation or undertaking to release any updates or revisions to financial condition, results of operations and business of TruSpine Technologies Limited the presentation to refmect any change in expectations or assumptions. Nothing in the and certain plans and objectives of the management of TruSpine Technologies Limited . presentation should be interpreted to mean that there has been no change in the afgairs of Forward-looking statements can generally be identified by the use of words such as TruSpine Technologies Limited since the date of the presentation. 'project', 'foresee', 'plan', 'expect', 'aim', 'intend', 'anticipate', 'believe', 'estimate', 'may', 'should', 'will' or similar expressions. Indications of, and guidance on, production targets, This presentation does not constitute investment, legal, taxation or other advice and the targeted output, development or timelines and future financial position and performance presentation does not take into account your investment objectives, financial situation are also forward-looking statements. nor particular needs. You are responsible for forming your own opinions and conclusions on such matters and should make your own independent assessment of the information contained in, or implied by, this presentation and seek independent professional advice in relation to such information and any action taken on the basis of the information. Con fj dential – not for distribution
03 The Mission TruSpine will be introducing pioneering products that propose a unique new approach to the greatest challenges facing spinal surgery, a vast and rapidly growing sector of the lucrative MedTech market. – Minimally intrusive devices that achieve spinal stabilisation while avoiding the complications inherent to the current technology. – Technologies that represent the first completely unique approach to spinal stabilisation in a global market marred by limited innovation and outdated legacy technologies. – The first truly new technology to be introduced in over 20 years. – Pipeline of intellectual property that will further expand the product offerings. Con fj dential – not for distribution
04 Overview – Established in 2015. – TruSpine Technologies Limited, acquired IP to support a suite of pioneering products within the spine market. – Established strategic partnership with MIT, CoorsTek, Emergo – Actively developing and commercialising key products: Faci-LOK™ & Cervi-FAS™ System, with others in the pipeline. – Highly experienced management team with proven track record. – IPO on AIM planned for 2019. RAISING UP TO USD 3 MILLION OF PRE-IPO FUNDING Con fj dential – not for distribution
05 Global Market Potential Th e g l o b a l s p i n a l f u s i o n m a r k e t i s c u r r e n t ly va l u e d at c i r c a $ 7. 1 B n p e r a n n u m , w i t h a n a n t i c i pat e d i n c r e a s e t o g r e at e r t h a n $ 1 0 b n b y 2 0 2 3 D r i v e r s • E m e r g i n g m a r k e t s – pa r t i c u l a r ly a s i a •A g e i n g p o p u l at i o n • P r e va l e n c e o f o b e s i t y • I n c r e a s i n g awa r e n e s s o f t r e at m e n t o p t i o n s Con fj dential – not for distribution
06 Management Team G R O U P C E O S I M O N S T E P H E N S G R O U P C H I E F F I N A N C I A L O F F I C E R G R O U P S A L E S & M A R K E T I N G D I R E C TO R N O R M A N LOT T P E T E R H O U G H TO N – B I O G RA P H I ES D E TA I L E D I N A P P E N D I X O N E – Con fj dential – not for distribution
07 Medical Advisory Board – Director Interventional Radiology, Stellaris Healthcare. M A R C R . H A M ET, – White Plains Hospital, White Plains, NY. M D, M BA – Assistant Clinical Professor Radiology, Columbia University, NY, NY. – Trained vascular surgeon, Former Director of ER. R I C HA R D A . BAS S I N, – Mount Sinai Hospital, New York, NY. M D, F. A .C. S . – Technical advisor to Goldman Sachs & Smith Barney regarding medical tech investments. – Board Certified Neurosurgeon. LEON K LIEM, – Director of the Hawaiian Neurosurgical Group MD – Adjuvent professor of Neurosurgery, University of Hawaii – Board Certified Neurosurgeon/Spine Surgeon. – Former Associate Professor Neurosurgery- State University of NY- Upstate Medical M A R K S M I T H , M D University. – Cardiovascular Surgeon - London/UK. – Vice Rector Ludes University Lugano - Switzerland PR O FES S O R A B DA L L A H RAWEH – Director of London Core Review Cardiothoracic Surgery Course for the Arab Countries Equity Compensation Con fj dential – not for distribution
08 What is Faci-LOK™ System? The first system specifically designed to stabilise a spinal segment without altering the anatomy in any way. Will be the least invasive and lowest risk of any system on the market, whilst also mitigating potential injury to nerve roots and other complications of screws. The Faci-LOK™ system does not irreversibly destroy the facet joint. - is fully reversible and can be removed without having altered the anatomy. - avoids deep bone infections which are associated even the most perfect placement of pedicle screws. - represents a significant cost saving and reduced surgery time. - will reduce the amount of exposure to radiation for patient, surgeon and staff. - has considerable diagnostic potential which could truly revolutionise the current practice of spinal surgery, as well as offering significant therapeutic benefits. Con fj dential – not for distribution
09 Global Fusion Market US$7.1 Bn/yr Fa c i- LO K™ Sys te m VERSUS PE D IC LE SC REWS – No invasion of vertebrae. – Screws inserted into vertebrae. – No risk of injury to nerve. – Risk of nerve Injury is a known complication. – Fully Reversible. - Risk of deep bone infection – Does not alter patient anatomy. – Permanent alteration to anatomy. – Less Surgical time. – Greater Surgical time & Anesthesia. – Less Anesthesia. – Unpredictable X-Ray exposure. – Significantly less X-Ray exposure. – Less ability to modify post placement in MIS settings. – Faci-LOK System enables surgeon to precisely position vertebrae post placement. Con fj dential – not for distribution
10 Current Technology Pedicle Screws introduced over 30 years ago “Pedicle screws are the most common implant used in spine surgery… unfortunately, unacceptably high rates of misplacements in vertebra persist” 1 The real problem… is the use of screws The REAL solution… avoid screws altogether 1 OrthoSpineNews, 30 March 2016 Con fj dential – not for distribution
11 Development Timeline NOV' 19 DEC' 19 MAR' 20 APR' 19 MAY' 19 JUN' 19 AUG' 19 OCT' 19 JAN' 20 FEB' 20 APR' 20 APR' 20 JUN' 20 JUL' 19 SEP' 19 MAY 20 MAY 20 JAN' A C T I V I T Y 17 PROTOTYPE REFINEMENT & TESTING 510K - PREPARATION 1 & FDA SUBMISSION SPECIALIST PRODUCT TESTING TEST MARKETING MANUFACTURING 2 & DISTRIBUTION 5 1 0 K P AT H WAY C O N F I R M E D B Y F D A 1 F D A C L E A R A N C E 2 M A R K E T R E A D Y Con fj dential – not for distribution
Recommend
More recommend
